Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts

Launched by ABRAMSON CANCER CENTER AT PENN MEDICINE · Apr 16, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a fast breast MRI (magnetic resonance imaging) as a way to help screen for breast cancer in African American women who are at average risk and have dense breasts. The goal is to see if this quicker MRI can effectively identify any potential issues that might be missed by standard mammograms. To be eligible for the study, participants must be African American females, have had a negative digital breast tomosynthesis (DBT) exam within the last 11 months, have heterogeneously or extremely dense breast tissue, and be free of any noticeable symptoms like lumps or unusual discharge.

Participants in the trial will undergo a fast breast MRI, which is a painless procedure that uses strong magnets and radio waves to create detailed images of the breast. This study is currently recruiting women, and those who are interested can reach out to the provided phone number or have their doctor refer them. It’s important to note that women who are pregnant, have had recent breast surgery, or are experiencing any breast symptoms are not eligible to participate. This trial aims to improve screening methods specifically for African American women, helping to ensure that they receive the best possible care.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. African American female
• • 2. Negative DBT examination within eleven months prior to recruitment
• • 3. Heterogeneoulsy and Extremely breast densities
• • 4. Clinically asymptomatic- no palpable masses or focal thickening, etc.
• Exclusion Criteria:
• • 1. Patients who are pregnant and lactating
• • 2. Patient who have not had a mammogram (DBT) in the past 11months
• • 3. Patients who are unwilling or unable to provide written informed consent
• • 4. Patients symptomatic for breast disease (e.g. experiencing discharge, lumps, ect.)
• • 5. Recent breast surgery in the past 2 years including breast enhancements (e.g. implants or injections)
• • 6. Patients who are unable to received an MRI with Gadolinium contrast
• • 7. Patients who have not had an MRI of the breast with the past year